Overview of Electrophysiological and Echocardiographic Findings and Outcomes with His Bundle Pacing for Cardiac Resynchronization
- 34 Downloads
Purpose of Review
His bundle pacing (HBP) is gaining popularity as a therapy for cardiac conduction disease. Utilization of the conduction system with HBP avoids the adverse effects of right ventricular pacing (RVP). Improvements in left ventricular (LV) function, New York Heart Association (NYHA) functional class, and quality of life (QOL) accompanying physiological activation induced by HBP attract attention. This is particularly important given the 30% non-responder rate from cardiac resynchronization therapy (CRT) studies; large number of patients with or at risk for pacing-induced cardiomyopathy and patients with poor coronary sinus (CS) targets.
The advantages of HBP as an alternative method for resynchronizing failing ventricles are supported by several recent studies, which are detailed in this review. HBP had significant clinical benefits in terms of LV ejection fraction (LVEF), NYHA functional class, and diuretic use. A growing number of case reports from several centers also support this growing trend. Additionally, success rates of in correcting bundle branch block have been reported in a number of studies and appear similar to traditional BiV pacing.
HBP is an attractive alternative to CRT in patients with heart failure and electrical conduction abnormalities. With improvements in guide-catheter design, lead structure, and overall operator experience, increased use and improved outcomes are expected in the next decade.
KeywordsHis bundle pacing RV pacing BiV pacing Cardiomyopathy
This work was supported by a Nihon Kohden/St. Jude Medical Research Fellowship to KY and National Institutes of Health grants HL125730 and DP2HL 142045 to OAA.
Compliance with Ethical Standards
Conflict of Interest
Koji Yoshie, and Olujimi A. Ajijola declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by the any of the authors.
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
- 8.Ajijola OA, Macias C, Garg V, Vorobiof G, Mally AH, Shivkumar K, et al. Feasibility of His bundle pacing in patients meeting criteria for cardiac resynchronization therapy and implantable cardioverter-defibrillator. Circulation. 2015;132:A20082.Google Scholar
- 12.Sweeney MO, Hellkamp AS, Ellenbogen KA, Greenspon AJ, Freedman RA, Lee KL, et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation. 2003;107(23):2932–7.CrossRefPubMedGoogle Scholar
- 17.•• Huang W, Su L, Wu S, Xu L, Xiao F, Zhou X, et al. Benefits of permanent His bundle pacing combined with atrioventricular node ablation in atrial fibrillation patients with heart failure with both preserved and reduced left ventricular ejection fraction. J Am Heart Assoc. 2017;6(4):e005309. This study showed clinical outcomes of HBP for the patients with heart failure. CrossRefPubMedPubMedCentralGoogle Scholar
- 19.Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation. 2013;127(3):e283–352.CrossRefPubMedGoogle Scholar
- 20.St John Sutton M, Plappert T, Adamson PB, Li P, Christman SA, Chung ES, et al. Left ventricular reverse remodeling with biventricular versus right ventricular pacing in patients with atrioventricular block and heart failure in the BLOCK HF trial. Circ Heart Fail. 2015;8(3):510–8.CrossRefPubMedGoogle Scholar
- 25.•• Ajijola OA, Upadhyay GA, Macias C, Shivkumar K, Tung R. Permanent His-bundle pacing for cardiac resynchronization therapy: initial feasibility study in lieu of left ventricular lead. Heart Rhythm. 2017;14(9):1353–61. The authors showed the feasibility of HBP as an alternative to coronary sinus lead for the CRT indicated patients. CrossRefPubMedGoogle Scholar
- 26.•• Sharma PS, Dandamudi G, Herweg B, Wilson D, Singh R, Naperkowski A, et al. Permanent His bundle pacing as an alternative to biventricular pacing for cardiac resynchronization therapy: a multi-center experience. Heart Rhythm. 2018;15(3):413–20. This paper evaluated the feasibility of HBP for the CRT indicated patients with failed left ventricular lead or nonresponder. CrossRefPubMedGoogle Scholar
- 28.Vijayaraman P, Naperkowski A, Ellenbogen KA, Dandamudi G. Electrophysiologic insights into site of atrioventricular block. JACC: Clin Electrophysiol. 2015;1(6):571–81.Google Scholar
- 29.•• Lustgarten DL, Crespo EM, Arkhipova-Jenkins I, Lobel R, Winget J, Koehler J, et al. His-bundle pacing versus biventricular pacing in cardiac resynchronization therapy patients: A crossover design comparison. Heart Rhythm. 2015;12(7):1548–57. This paper showed the clinical response of HBP as an alternative to traditional pacing method for the patients with CRT indication. CrossRefPubMedGoogle Scholar
- 31.Vijayaraman P, Ellenbogen KA, Dandamudi G. Longitudinal dissociation in the His bundle: persistent bundle branch block can be corrected by permanent His bundle pacing. Circulation. 2014;130:A17180.Google Scholar
- 32.Tung R. His bundle pacing versus coronary sinus pacing for cardiac resynchronization therapy (His-SYNC). Clinical Trials.gov. 2018. https://clinicaltrials.gov/ct2/show/study/NCT02700425. Accessed 18 Jan 2018.
- 33.Zachary W. The His Optimised Pacing Evaluation for Heart Failure Trial (HOPE-HF). Clinical Trials.gov. 2017. https://clinicaltrials.gov/ct2/show/record/NCT02671903. Accessed 5 Sep 2017.
- 34.Weijiang H. Comparison of His bundle pacing and bi-ventricular pacing in heart failure with atrial fibrillation. ClinicalTrials.Gov. 2017. https://clinicaltrials.gov/ct2/show/record/NCT02805465. Accessed 20 Jun 2016.